440 related articles for article (PubMed ID: 15753933)
1. A TCP-NTCP estimation module using DVHs and known radiobiological models and parameter sets.
Warkentin B; Stavrev P; Stavreva N; Field C; Fallone BG
J Appl Clin Med Phys; 2004; 5(1):50-63. PubMed ID: 15753933
[TBL] [Abstract][Full Text] [Related]
2. Limitations of a convolution method for modeling geometric uncertainties in radiation therapy: the radiobiological dose-per-fraction effect.
Song W; Battista J; Van Dyk J
Med Phys; 2004 Nov; 31(11):3034-45. PubMed ID: 15587657
[TBL] [Abstract][Full Text] [Related]
3. Radiobiological impact of reduced margins and treatment technique for prostate cancer in terms of tumor control probability (TCP) and normal tissue complication probability (NTCP).
Jensen I; Carl J; Lund B; Larsen EH; Nielsen J
Med Dosim; 2011; 36(2):130-7. PubMed ID: 20488692
[TBL] [Abstract][Full Text] [Related]
4. Radiobiological impact of dose calculation algorithms on biologically optimized IMRT lung stereotactic body radiation therapy plans.
Liang X; Penagaricano J; Zheng D; Morrill S; Zhang X; Corry P; Griffin RJ; Han EY; Hardee M; Ratanatharathom V
Radiat Oncol; 2016 Jan; 11():10. PubMed ID: 26800883
[TBL] [Abstract][Full Text] [Related]
5. Dosimetric and radiobiological impact of dose fractionation on respiratory motion induced IMRT delivery errors: a volumetric dose measurement study.
Duan J; Shen S; Fiveash JB; Popple RA; Brezovich IA
Med Phys; 2006 May; 33(5):1380-7. PubMed ID: 16752574
[TBL] [Abstract][Full Text] [Related]
6. Toolkit for determination of dose-response relations, validation of radiobiological parameters and treatment plan optimization based on radiobiological measures.
Mavroidis P; Tzikas A; Papanikolaou N; Lind BK
Technol Cancer Res Treat; 2010 Oct; 9(5):523-37. PubMed ID: 20815424
[TBL] [Abstract][Full Text] [Related]
7. Biological optimization of heterogeneous dose distributions in systemic radiotherapy.
Strigari L; D'Andrea M; Maini CL; Sciuto R; Benassi M
Med Phys; 2006 Jun; 33(6):1857-66. PubMed ID: 16872093
[TBL] [Abstract][Full Text] [Related]
8. Response-probability volume histograms and iso-probability of response charts in treatment plan evaluation.
Mavroidis P; Ferreira BC; Lopes Mdo C
Med Phys; 2011 May; 38(5):2382-97. PubMed ID: 21776773
[TBL] [Abstract][Full Text] [Related]
9. [Construction of radiobiological models as TCP (tumor control probability) and NTCP (normal tissue complication probability): from dose to clinical effects prediction].
Chaikh A; Thariat J; Thureau S; Tessonnier T; Kammerer E; Fontbonne C; Dubray B; Balosso J; Fontbonne JM
Cancer Radiother; 2020 Jun; 24(3):247-257. PubMed ID: 32220563
[TBL] [Abstract][Full Text] [Related]
10. On the use of published radiobiological parameters and the evaluation of NTCP models regarding lung pneumonitis in clinical breast radiotherapy.
Svolos P; Tsougos I; Kyrgias G; Kappas C; Theodorou K
Australas Phys Eng Sci Med; 2011 Apr; 34(1):69-81. PubMed ID: 21213098
[TBL] [Abstract][Full Text] [Related]
11. "SABER": A new software tool for radiotherapy treatment plan evaluation.
Zhao B; Joiner MC; Orton CG; Burmeister J
Med Phys; 2010 Nov; 37(11):5586-92. PubMed ID: 21158270
[TBL] [Abstract][Full Text] [Related]
12. Radiobiological indices that consider volume: a review.
Holloway L; Hoban P; Metcalfe P
Australas Phys Eng Sci Med; 2002 Jul; 25(2):47-57. PubMed ID: 12219845
[TBL] [Abstract][Full Text] [Related]
13. A theoretical approach to the problem of dose-volume constraint estimation and their impact on the dose-volume histogram selection.
Schinkel C; Stavrev P; Stavreva N; Fallone BG
Med Phys; 2006 Sep; 33(9):3444-59. PubMed ID: 17022241
[TBL] [Abstract][Full Text] [Related]
14. A radiobiological model for the relative biological effectiveness of high-dose-rate 252Cf brachytherapy.
Rivard MJ; Melhus CS; Zinkin HD; Stapleford LJ; Evans KE; Wazer DE; Odlozilíková A
Radiat Res; 2005 Sep; 164(3):319-23. PubMed ID: 16137205
[TBL] [Abstract][Full Text] [Related]
15. IMRT: improvement in treatment planning efficiency using NTCP calculation independent of the dose-volume-histogram.
Grigorov GN; Chow JC; Grigorov L; Jiang R; Barnett RB
Med Phys; 2006 May; 33(5):1250-8. PubMed ID: 16752559
[TBL] [Abstract][Full Text] [Related]
16. A method to visualize the uncertainty of the prediction of radiobiological models.
Zhang L; Hub M; Thieke C; Floca RO; Karger CP
Phys Med; 2013 Sep; 29(5):556-61. PubMed ID: 23260766
[TBL] [Abstract][Full Text] [Related]
17. Three-dimensional heart dose reconstruction to estimate normal tissue complication probability after breast irradiation using portal dosimetry.
Louwe RJ; Wendling M; van Herk MB; Mijnheer BJ
Med Phys; 2007 Apr; 34(4):1354-63. PubMed ID: 17500466
[TBL] [Abstract][Full Text] [Related]
18. Influence of SBRT fractionation on TCP and NTCP estimations for prostate cancer.
Sukhikh ES; Sukhikh LG; Taletsky AV; Vertinsky AV; Izhevsky PV; Sheino IN
Phys Med; 2019 Jun; 62():41-46. PubMed ID: 31153397
[TBL] [Abstract][Full Text] [Related]
19. Radiobiological parameters in a tumour control probability model for prostate cancer LDR brachytherapy.
Her EJ; Reynolds HM; Mears C; Williams S; Moorehouse C; Millar JL; Ebert MA; Haworth A
Phys Med Biol; 2018 Jun; 63(13):135011. PubMed ID: 29799812
[TBL] [Abstract][Full Text] [Related]
20. IMRT optimization: variability of solutions and its radiobiological impact.
Mattia M; Del Giudice P; Caccia B
Med Phys; 2004 May; 31(5):1052-60. PubMed ID: 15191292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]